` Comparison: CPH vs NOVN - Alpha Spread

CPH
vs
NOVN

Over the past 12 months, CPH has underperformed NOVN, delivering a return of 0% compared to the NOVN's +31% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CPH
NOVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CPH Intrinsic Value
Not Available
NOVN Intrinsic Value
107.28 CHF
Overvaluation 14%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Creso Pharma Ltd
ASX:CPH
0.008 AUD
Novartis AG
SIX:NOVN
124.5 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CPH, NOVN

CPH
NOVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Creso Pharma Ltd
Revenue
Novartis AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CPH, NOVN

CPH
NOVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Creso Pharma Ltd
ASX:CPH
Novartis AG
SIX:NOVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CPH
4.2%
NOVN
75.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

Operating Margin

CPH
-224.7%
NOVN
33.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

Net Margin

CPH
-373.7%
NOVN
24.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

FCF Margin

CPH
-201.2%
NOVN
27.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

ROE

CPH
-147%
NOVN
31%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

ROA

CPH
-86.3%
NOVN
13.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

ROIC

CPH
-60.8%
NOVN
17.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

ROCE

CPH
-88.4%
NOVN
23.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Creso Pharma Ltd
Novartis AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CPH, NOVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CPH, NOVN

Loading
CPH
NOVN
Difference
www.alphaspread.com

Performance By Year
CPH, NOVN

Loading
CPH
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CPH to other stocks
LLY
Eli Lilly and Co
JNJ
Johnson & Johnson
ROG
Roche Holding AG
AZN
AstraZeneca PLC
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account